Cargando…

Ertapenem-induced neurotoxicity in an end-stage renal disease patient on intermittent haemodialysis: a case report

BACKGROUND: Carbapenem-induced neurotoxicity is an unusual side effect, with seizure being the most commonly reported symptom. Among the carbapenems, imipenem-cilastin is classically associated with the most severe neurotoxicity side effects. Carbapenem is mainly excreted by the kidney and its half-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shahar, Shamira, Arimuthu, Durga A., Mazlan, Sadanah Aqashiah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644511/ https://www.ncbi.nlm.nih.gov/pubmed/36348388 http://dx.doi.org/10.1186/s12882-022-02980-8

Ejemplares similares

2786. Characterizing Ertapenem Neurotoxicity: A Systematic Review
por: Mitaka, Hayato, et al.
Publicado: (2023)

Ertapenem-Induced Neurotoxicity: A Literature Review of Clinical Characteristics and Treatment Outcomes
por: Wang, Chunjiang, et al.
Publicado: (2023)

Inflammatory markers in end-stage renal disease patients on haemodialysis
por: Abdel-Messeih, Phebe Lotfy, et al.
Publicado: (2020)

Ertapenem-Induced Thrombocytosis
por: Docobo, Ramon A, et al.
Publicado: (2017)

Restless Legs Syndrome in End Stage Renal Disease Patients on Haemodialysis
por: Haider, Irfan, et al.
Publicado: (2014)

Ertapenem-Induced Encephalopathy in a Patient With Normal Renal Function
por: Sutton, S. Scott, et al.
Publicado: (2017)

Prolonged Cefepime-Induced Neurotoxicity in a Patient with End-Stage Renal Disease
por: Nguyen, Dorothy Dao, et al.
Publicado: (2022)

Sphingobacterium spiritivorum infection in a patient with end stage renal disease on haemodialysis
por: Gupta, Amit, et al.
Publicado: (2016)

Single-dose baclofen-induced neurotoxicity in a patient with end stage renal disease: case report
por: Khazneh, Emad, et al.
Publicado: (2018)

The prevalence of risk factors for foot ulceration in patients with end stage renal disease on haemodialysis
por: Kaminski, Michelle, et al.
Publicado: (2011)

Causes of end stage renal failure among haemodialysis patients in Khartoum State/Sudan
por: Banaga, Amin S. I., et al.
Publicado: (2015)

Do Transferrin Levels Predict Haemodialysis Adequacy in Patients with End-Stage Renal Disease?
por: Tarantino, Giovanni, et al.
Publicado: (2019)

Dietary Practice among the Patients with End Stage Renal Disease undergoing Maintenance Haemodialysis
por: Lamichhane (Dulal), Sangita, et al.
Publicado: (2018)

Catheter-Related Bloodstream Infections and Catheter Colonization among Haemodialysis Patients: Prevalence, Risk Factors, and Outcomes
por: Shahar, Shamira, et al.
Publicado: (2021)

2283. The Incidence and Risk Factors for Neurotoxicity in Patients on Ertapenem Therapy: a Retrospective Case- Control Study
por: Fong, Raymond K C, et al.
Publicado: (2019)

Cell-free DNA as a marker for the outcome of end-stage renal disease patients on haemodialysis
por: Coimbra, Susana, et al.
Publicado: (2020)

Ertapenem Resistance of Escherichia coli
por: Lartigue, Marie-Frédérique, et al.
Publicado: (2007)

Changes of Left and Right Ventricle Mechanics and Function in Patients with End-Stage Renal Disease Undergoing Haemodialysis
por: Tamulėnaitė, Eglė, et al.
Publicado: (2018)

A Case of Ertapenem Neurotoxicity Resulting in Vocal Tremor and Altered Mentation in a Dialysis Dependent Liver Transplant Patient
por: Hanna, Ramy M., et al.
Publicado: (2018)

Use of complementary and alternative medicine by patients with end-stage renal disease on haemodialysis in Trinidad: A descriptive study
por: Bahall, Mandreker
Publicado: (2017)

Evaluation of the quality of care of a haemodialysis public-private partnership programme for patients with end-stage renal disease
por: Chen, Julie Y., et al.
Publicado: (2016)

Molecular characterization and genotyping of hepatitis C virus from Sudanese end-stage renal disease patients on haemodialysis
por: Zitha, Trodia, et al.
Publicado: (2022)

Psychometric properties of End Stage Renal Disease-Adherence Questionnaire-Sinhalese version among patients receiving haemodialysis
por: Lasanthika, Chalani, et al.
Publicado: (2023)

The Case for Intermittent Carbapenem Dosing in Stable Haemodialysis Patients
por: Ho, Vanda, et al.
Publicado: (2020)

Ertapenem rescue therapy in hidradenitis suppurativa
por: Chahine, Adam A., et al.
Publicado: (2018)

A Case Report of Valacyclovir-Associated Neurotoxicity in End-Stage Renal Disease: A Rare but Preventable Side Effect
por: Bo, Amber Y, et al.
Publicado: (2023)

A Rare Case of Late-Onset Ertapenem-Induced Encephalopathy
por: Teague, Alexander J, et al.
Publicado: (2023)

Plasma protein-bound di-tyrosines as biomarkers of oxidative stress in end stage renal disease patients on maintenance haemodialysis
por: Colombo, Graziano, et al.
Publicado: (2017)

The cardiovascular determinants of physical function in patients with end-stage kidney disease on haemodialysis
por: Adenwalla, Sherna F., et al.
Publicado: (2020)

Neurotoxicity following the Ingestion of Bilimbi Fruit (Averrhoa bilimbi) in an End-Stage Renal Disease Patient on Hemodialysis
por: Caetano, Camille Pereira, et al.
Publicado: (2017)

Investigation into haemodynamic stability during intermittent haemodialysis in the critically ill
por: Docking, R, et al.
Publicado: (2012)

Ertapenem for treatment of osteomyelitis: a case series
por: Goswami, Neela D, et al.
Publicado: (2011)

Antimicrobial prophylaxis in colorectal surgery: focus on ertapenem
por: de Lalla, Fausto
Publicado: (2009)

The treatment of diabetic foot infections: focus on ertapenem
por: Edmonds, Michael
Publicado: (2009)

The Radiation Sterilization of Ertapenem Sodium in the Solid State
por: Kilińska, Karolina, et al.
Publicado: (2019)

602. Clinical Outcomes of Ertapenem in Patients with Hypoalbuminemia
por: Gavaghan, Victoria, et al.
Publicado: (2022)

Developing a classification system for haemoglobin management in patients with end-stage renal disease on haemodialysis: a secondary data analysis
por: Kesztyüs, Tibor, et al.
Publicado: (2017)

Preliminary study of hypoxia-related cardiovascular mediator-markers in patients with end-stage renal disease with and without diabetes and the effects of haemodialysis
por: Treweeke, A., et al.
Publicado: (2017)

A Cost Analysis of Haemodialysis and Peritoneal Dialysis for the Management of End-Stage Renal Failure At an Academic Hospital in Pretoria, South Africa
por: Makhele, Letlhogonolo, et al.
Publicado: (2019)

Pharmacokinetics of Nirmatrelvir and Ritonavir in COVID-19 Patients with End-Stage Renal Disease on Intermittent Hemodialysis
por: Lingscheid, Tilman, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_eh90vr5g3euuvmmjsianjbq3ke